We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. Vanguard Primecap stands out for its seasoned management and high-conviction multimanager system. The remainder of this analysis is from July 7, 2023.
Vanguard PRIMECAP Inv VPMCX
- NAV / 1-Day Return 174.64 / +0.98 %
- Total Assets 78.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.380%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Large Blend
- Investment Style Large Growth
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 0.90%
- Turnover 4%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis VPMCX
Will VPMCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 41.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 13.25 | 10.4 Bil | Healthcare |
Micron Technology Inc | 3.96 | 3.1 Bil | Technology |
Amgen Inc | 3.57 | 2.8 Bil | Healthcare |
KLA Corp | 3.52 | 2.8 Bil | Technology |
Microsoft Corp | 3.45 | 2.7 Bil | Technology |
FedEx Corp | 3.25 | 2.6 Bil | Industrials |
Adobe Inc | 2.96 | 2.3 Bil | Technology |
Biogen Inc | 2.70 | 2.1 Bil | Healthcare |
Texas Instruments Inc | 2.62 | 2.1 Bil | Technology |
Alphabet Inc Class A | 2.55 | 2.0 Bil | Communication Services |